# BACLOFEN
> **ANDA217324** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-02-22
## Drug
- **FDA Application Number:** ANDA217324
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BACLOFEN
- **Generic name:** BACLOFEN
- **Active ingredients:** BACLOFEN
- **Dosage form:** INJECTABLE
- **Route:** INTRATHECAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Nexus Pharmaceuticals LLC
- **First approval:** 2023-02-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217324)
---
*AI Analytics · CC0 1.0*